“Hepatitis b”的搜索结果，显示 171-180 项，共有 9447 项

1. 血液科- 临床试验- 妙佑医疗国际

   ... B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and ...

2. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

3. 外科 - 医生 - 妙佑医疗国际

   ... Hepatitis C, Hepatitis B, No...nalcoholic fatty liver disease, Primary biliary cholangitis, Cholangiocarcinoma, Primary sclerosing cholangitis, Wilson's ...

4. 血液科- 临床试验- 妙佑医疗国际

   Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able ...

5. 血液科- 临床试验- 妙佑医疗国际

   Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able ...

6. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

7. Mayo Clinic Physician Update - May 2026

   Page 1.

8. 血液科- 临床试验- 妙佑医疗国际

   Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma. Rochester, Minn., Scottsdale/Phoenix ...

9. 皮肤 B 细胞淋巴瘤- 在 Mayo Clinic 治疗 - 妙佑医疗国际

   详细了解此类非霍奇金淋巴瘤的症状、诊断和治疗方法。

10. 血液科- 临床试验- 妙佑医疗国际

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...